MedPath

Bare Platinum Coils Versus Second-generation Hydrocoils

Not Applicable
Terminated
Conditions
Aneurysm, Ruptured
Intracranial Aneurysm
Registration Number
NCT04988503
Lead Sponsor
Seoul National University Hospital
Brief Summary

Comparison of clinical and radiological outcomes between bare platinum coil group and second-generation hydrogel coils for treatment of ruptured intracranial aneurysms.

Detailed Description

The investigators aimed to analyze whether the use of second-generation hydrogel coils for the treatment of ruptured intracranial aneurysms improves clinical and angiographic outcomes compared with the use of bare platinum coils.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • 19 year old or older
  • untreated ruptured intracranial aneurysms with an anatomy such that endovascular treatment with either bare platinum or second-generation hydrogel coils was considered feasible.
  • person who agreed to study
Exclusion Criteria
  • contrast allgery (+)
  • combined other intracranial lesions (tumor, moyamoya disease, cerebral vascular diseases)
  • ineligible for coil embolization

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
any recurrence rate after treatmentduring 12 months after coil embolization

any recurrence rate at 12 months after coil embolization

Secondary Outcome Measures
NameTimeMethod
rate of retreatment during 12 months follow-up periodrate of retreatment during 12 months follow-up period

rate of retreatment during 12 months follow-up period

packing density (%) after coil embolizationpacking density (%) after coil embolization

packing density (%) after coil embolization

Procedural complicationduring coil embolization

Procedural complication

delayed cerebral ischemia during 12-month follow-up perioddelayed cerebral ischemia during 12-month follow-up period

delayed cerebral ischemia during 12-month follow-up period

good clinical outcome (mRS score ≤ 2) at 12-month follow-up periodgood clinical outcome (mRS score ≤ 2) at 12-month follow-up period

good clinical outcome (mRS score ≤ 2) at 12-month follow-up period

rate of ventriculoperitoneal shunt during 12-month follow-up periodrate of ventriculoperitoneal shunt during 12-month follow-up period

rate of ventriculoperitoneal shunt during 12-month follow-up period

coil's ease of manipulationduring coil embolization

coil's ease of manipulation

Trial Locations

Locations (3)

Chungnam National University Sejong Hospital

🇰🇷

Sejong, Chungnam, Korea, Republic of

Pusan National University Yangsan Hospital

🇰🇷

Yangsan, Gyeongsangnam-do, Korea, Republic of

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si, Korea, Republic of

Chungnam National University Sejong Hospital
🇰🇷Sejong, Chungnam, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.